≤4 cm 实性肾肿块透明细胞癌的肾脏 CT 算法验证
本回顾性研究纳入中国两家中心 217 例 ≤4 cm 实性肾肿块患者,以组织病理为参考标准,验证肾脏 CT 算法诊断透明细胞肾细胞癌的效能。每家中心 3 名放射科医师独立评估衰减比、异质性及 CT 评分,结果显示该算法 AUC 为 0.829–0.842,在 CT 评分 ≥4 阈值下敏感度 68.8%–75.0%,特异度 72.9%–83.3%,不同经验水平读片者间无显著差异。
要点
- CT 评分 ≥4 可作为 ≤4 cm 实性肾肿块提示透明细胞癌的参考阈值
- 衰减比和 CT 评分观察者间一致性几乎完美(κ=0.82–0.85),异质性评分一致性较高
- 该低费用算法在不同经验读片者和不同中心间诊断效能稳定
核心结论
- 肾脏 CT 评分对 ≤4 cm 实性肾肿块中透明细胞肾细胞癌的诊断具有良好特异性和可重复性
- CT 评分 ≥4 的截断值在不同读片者和不同中心间诊断效能稳定
研究设计与样本
- 回顾性研究,纳入 2023 年 1 月至 2025 年 12 月中国两家中心 217 例患者(217 个 ≤4 cm 实性肾肿块)
- 中心 1 纳入 121 例(62 例 ccRCC,59 例非 ccRCC),中心 2 纳入 96 例(48 例 ccRCC,48 例非 ccRCC)
- 以组织病理学为最终诊断参考标准,每家中心 3 名放射科医师独立评估衰减比、异质性和 CT 评分
诊断标准与关键数值
- 基于原始有序 CT 评分的 ROC 分析显示,中心 1 AUC 为 0.823–0.837(95% CI: 0.753–0.904),中心 2 AUC 为 0.830–0.856(95% CI: 0.752–0.927)
- 总体 AUC 为 0.829–0.842(95% CI: 0.778–0.891)
- 以 CT 评分 ≥4 为截断值时,敏感度为 68.8%–75.0%(95% CI: 53.7%–86.4%)
- 以 CT 评分 ≥4 为截断值时,特异度为 72.9%–83.3%(95% CI: 59.7%–92.5%)
- 以 CT 评分 ≥4 为截断值时,准确率为 71.9%–79.2%(95% CI: 63.0%–86.8%),PPV 为 73.3%–81.8%(95% CI: 60.3%–91.8%),NPV 为 70.5%–76.9%(95% CI: 57.4%–87.5%)
临床应用与阅片要点
- 衰减比的观察者间一致性几乎完美(κ=0.82–0.85),适合日常阅片中作为可重复的客观指标
- 异质性评分的一致性为 substantial(κ=0.72–0.76),读片时需注意主观判断可能带来的变异
- 该算法在不同经验水平读片者间 AUC 无显著差异(所有 P > 0.05),低年资医师亦可应用
局限性
- 回顾性研究设计,存在选择偏倚可能
- 原文指出该算法有待前瞻性验证
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To externally validate a renal CT algorithm for diagnosing clear cell renal cell carcinoma (ccRCC) in solid renal masses ≤ 4 cm and assess inter-reader agreement according to reader experience and across institutions.
METHODS: This retrospective study included 217 patients (217 masses ≤ 4 cm) from two Chinese centers enrolled between January 2023 and December 2025. Histopathology served as the reference standard for final diagnosis. At each center, three radiologists independently evaluated attenuation ratio, heterogeneity, and CT score. Fleiss' weighted kappa was used to assess inter-reader agreement. Receiver operating characteristic (ROC) curve analysis was performed on original ordinal CT scores to calculate AUC, and sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV) were calculated at the cutoff CT score ≥ 4.
RESULTS: Center 1 included 121 patients (62 with ccRCC and 59 with non-ccRCC), and Center 2 included 96 patients (48 with ccRCC and 48 with non-ccRCC). Inter-reader agreement was almost perfect for attenuation ratio and CT scores (κ = 0.82-0.85) and substantial for heterogeneity score (κ = 0.72-0.76). Based on ordinal scores, the area under the curve (AUC) ranged from 0.823 to 0.837 (95% CI: 0.753-0.904) in Center 1 and from 0.830 to 0.856 (95% CI: 0.752-0.927) in Center 2, with overall AUC 0.829-0.842 (95% CI: 0.778-0.891). At CT score ≥ 4, sensitivity, specificity, accuracy, PPV, and NPV ranged from 68.8% to 75.0% (95% CI: 53.7%-86.4%), 72.9% to 83.3% (95% CI: 59.7%-92.5%), 71.9% to 79.2% (95% CI: 63.0%-86.8%), 73.3% to 81.8% (95% CI: 60.3%-91.8%), and 70.5% to 76.9% (95% CI: 57.4%-87.5%), respectively. No significant differences in AUC were found among readers with different experience levels (all P > 0.05).
CONCLUSION: The renal CT score offers favorable specificity and reproducibility for diagnosing ccRCC in small (≤ 4 cm) renal masses. The CT cutoff of ≥ 4 yields stable diagnostic performance across readers and centers. This low-cost algorithm shows promise as a potential tool for primary healthcare settings, pending prospective validation.
引用
- Zhang, Li, Han, et al. Renal CT algorithm for evaluating clear cell carcinoma in solid renal masses ≤ 4 cm: a retrospective chinese two-center validation study. Abdom Radiol (NY). 2026. PMID: 42371022. doi:10.1007/s00261-026-05658-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。